Biomea Fusion, Inc.

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

BMEA$0.60+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets

(in thousands, except share and per share data)

	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$58,279	$176,866
Prepaid expenses and other current assets	10,053	2,315
Total current assets	68,332	179,181
Property and equipment, net	3,766	5,159
Restricted cash	369	370
Other assets	619	5,503
Operating lease right-of-use assets	6,852	9,714
Total assets	$79,938	$199,927
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$12,932	$6,851
Accrued expenses and other current liabilities	6,662	13,543
Operating lease liabilities, current	2,079	2,466
Total current liabilities	21,673	22,860
Operating lease liabilities, non-current	6,692	7,830
Total liabilities	28,365	30,690
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 0 shares issued and outstanding as of December 31, 2024 and December 31, 2023	—	—
Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 36,310,713 and 35,866,610 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	4	4
Additional paid-in capital	438,820	418,058
Accumulated deficit	(387,251)	(248,825)
Total stockholders' equity	51,573	169,237
Total liabilities and stockholders' equity	$79,938	$199,927

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.